eli lilly glp 1 products New GLP-1 Pill Foundayo (Orforglipron) Gets FDA Approval for Obesity Eli Lilly's Obesity Pill Shows

Description

The percentage of commercial plans covering any obesity medication dropped from 48% in 2023 to 31% in 2026 (KFF Employer Health Benefits Survey, 2026)

By six months, most people have regained a measurable portion of their lost weight, and by one year, the regain is typically substantial

This product utilizes only vegetable capsules that are free of animal products

doi: 10.1210/er.2006-0007 [DOI] [PubMed] [Google Scholar] 134

Qsymia side effects Common side effects include: Tingling hands and feet Dizziness Altered sense of taste Insomnia Constipation Dry mouth Serious side effects include: Certain birth defects (cleft lip and cleft palate) Faster heart rate Suicidal thoughts or actions Eye problems that could lead to permanent vision loss if not treated Women who might become pregnant should get a pregnancy test before taking Qsymia and should use birth control and get monthly pregnancy tests while on the drug